All Wales Medicines Strategy Group Final Appraisal Report – Dasatinib (Sprycel®) Lymphoid blast CML and PH+ ALL.
Allbwn ymchwil: Llyfr/Adroddiad › Adroddiad Comisiwn
StandardStandard
All Wales Medicines Strategy Group Final Appraisal Report – Dasatinib (Sprycel®) Lymphoid blast CML and PH+ ALL. / Hughes, D.; Hughes, D.A.; All Wales Strategy Group., [No Value].
2007 gol. Unknown, 2007.
2007 gol. Unknown, 2007.
Allbwn ymchwil: Llyfr/Adroddiad › Adroddiad Comisiwn
HarvardHarvard
Hughes, D, Hughes, DA & All Wales Strategy Group., NV 2007, All Wales Medicines Strategy Group Final Appraisal Report – Dasatinib (Sprycel®) Lymphoid blast CML and PH+ ALL. 2007 gol., Unknown.
APA
Hughes, D., Hughes, D. A., & All Wales Strategy Group., N. V. (2007). All Wales Medicines Strategy Group Final Appraisal Report – Dasatinib (Sprycel®) Lymphoid blast CML and PH+ ALL. (2007 gol.) Unknown.
CBE
Hughes D, Hughes DA, All Wales Strategy Group. NV 2007. All Wales Medicines Strategy Group Final Appraisal Report – Dasatinib (Sprycel®) Lymphoid blast CML and PH+ ALL. 2007 gol. Unknown.
MLA
Hughes, D., D.A. Hughes a [No Value] All Wales Strategy Group. All Wales Medicines Strategy Group Final Appraisal Report – Dasatinib (Sprycel®) Lymphoid blast CML and PH+ ALL. 2007 udg. Unknown. 2007.
VancouverVancouver
Hughes D, Hughes DA, All Wales Strategy Group. NV. All Wales Medicines Strategy Group Final Appraisal Report – Dasatinib (Sprycel®) Lymphoid blast CML and PH+ ALL. 2007 gol. Unknown, 2007.
Author
RIS
TY - BOOK
T1 - All Wales Medicines Strategy Group Final Appraisal Report – Dasatinib (Sprycel®) Lymphoid blast CML and PH+ ALL.
AU - Hughes, D.
AU - Hughes, D.A.
AU - All Wales Strategy Group., [No Value]
PY - 2007/1/1
Y1 - 2007/1/1
UR - http://www.wales.nhs.uk/sites3/Documents/371/FAR%20dasatinib%20(Sprycel)%20PH%2BALL.pdf
M3 - Commissioned report
BT - All Wales Medicines Strategy Group Final Appraisal Report – Dasatinib (Sprycel®) Lymphoid blast CML and PH+ ALL.
PB - Unknown
ER -